Literature DB >> 11028913

Regulation of transcription factors by protein degradation.

J M Desterro1, M S Rodriguez, R T Hay.   

Abstract

The level of transcription factors is tightly controlled by their rates of synthesis and degradation. Many critical factors are maintained at an appropriate level by targeted addition of ubiquitin and degradation via the proteasome. Whereas ubiquitination targets modified proteins for degradation, modification of substrates by the family of ubiquitin-like proteins does not target the proteins for degradation but can alter the stability and other properties of the modified proteins. Here we discuss the elaborate mechanisms that have evolved to allow specific recognition of substrates targeted for modification. Specific examples are discussed to illustrate the different mechanisms involved and the importance of regulated degradation in diseases such as cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11028913     DOI: 10.1007/pl00000760

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  27 in total

Review 1.  Bromodomain motifs and "scaffolding"?

Authors:  G V Denis
Journal:  Front Biosci       Date:  2001-09-01

Review 2.  Transcriptional regulation of hepatic stellate cell activation.

Authors:  D A Mann; D E Smart
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

3.  Abduction and asylum in the lives of transcription factors.

Authors:  Anat Burger; Aleksandra M Walczak; Peter G Wolynes
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

4.  Role of the BCA2 ubiquitin E3 ligase in hormone responsive breast cancer.

Authors:  Angelika M Burger; Fathima Kona; Yutaka Amemiya; Yuguang Gao; Stephanie Bacopulos; Arun K Seth
Journal:  Open Cancer J       Date:  2010

Review 5.  The ubiquitin-proteasome system in myocardial ischaemia and preconditioning.

Authors:  Saul R Powell; Andras Divald
Journal:  Cardiovasc Res       Date:  2009-09-30       Impact factor: 10.787

6.  The proteasome inhibitor Velcade enhances rather than reduces disease in mouse hepatitis coronavirus-infected mice.

Authors:  Matthijs Raaben; Guy C M Grinwis; Peter J M Rottier; Cornelis A M de Haan
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

7.  Upregulation of proteasome activity rescues cardiomyocytes following pulse treatment with a proteasome inhibitor.

Authors:  Ping Wang; Justine Calise; Keren Powell; Andras Divald; Saul R Powell
Journal:  Am J Cardiovasc Dis       Date:  2014-01-15

8.  Self-association of the Gal4 inhibitor protein Gal80 is impaired by Gal3: evidence for a new mechanism in the GAL gene switch.

Authors:  Onur Egriboz; Sudip Goswami; Xiaorong Tao; Kathleen Dotts; Christie Schaeffer; Vepkhia Pilauri; James E Hopper
Journal:  Mol Cell Biol       Date:  2013-07-15       Impact factor: 4.272

9.  The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression.

Authors:  Sandii Brimble; Edith E Wollaston-Hayden; Chin Fen Teo; Andrew C Morris; Lance Wells
Journal:  Curr Signal Transduct Ther       Date:  2010

10.  Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation.

Authors:  Hitomi Matsuzaki; Hiroaki Daitoku; Mitsutoki Hatta; Keiji Tanaka; Akiyoshi Fukamizu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.